ArticleBMC nephrology2020

Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.

Mira Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.